Gluten sensitivity among the patients with depression and the possibility of therapeutic effect of gluten free diet

Gluten sensitivity among the patients with depression and the possibility of therapeutic effect of gluten free diet - Gluten sensitivity among the patients with depression and the possibility of therapeutic effect of gluten free diet

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034678

Enrollment

100

Registered

2018-12-01

Start date

2018-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

gluten sensitive patients with depression have gluten free diet for two weeks. Patients whose symptoms are improved (Score decrease twenty percents or CGI-I score above three at two weeks) continue gl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient who met the criteria of depression in the DSM-5 patient who can understand the purpose of this study and be approved to participate by doctor patient who can provide written informed consent

Exclusion criteria

Exclusion criteria: patient with remarkable excitement, violent action, self-injurious behavior patient with social behavior patinet who can't provide written informed consent patient who have substance abuse or dependent

Design outcomes

Primary

Measure	Time frame
Assessment of gluten sensitivity is determined by the titer of tissue transglutaminase IgA antibody, the deamidated gliadin peptide IgA antibody, gliadin IgA antibody, gliadin IgGa nti body.	—

Countries

Japan

Contacts

Public ContactYamada Hisashi

hyogo college of medicine department of psychiatry

hisa0820@hyo-med.ac.jp0798-45-6051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026